Alzheimer's Society blog

Read real stories from people affected by dementia, and find out about the latest dementia news, research and campaigns.

No filters currently applied. Choose more or apply selected filters.
Information
Information

Party conference season is a prime opportunity for Alzheimer’s Society to meet with key decision makers and put our calls front and centre of the political landscape.

Research
Research

Lecanemab made headlines as the first MHRA-approved drug in the UK to slow early-stage Alzheimer’s disease, but it has not been recommended for use on the NHS. Here is what we know so far about this breakthrough Alzheimer's drug. 

Real stories
Real stories

Both of Sania Rehman’s grandfathers had dementia, but their experiences were very different. After a career in IT, she has now become a Local Services Manager for Team Sahara (meaning ‘support’ in Urdu) who assist South Asian families to access culturally appropriate help.

Research
Research
Artificial intelligence technology could be a game-changer for people affected by dementia. Find out why Alzheimer’s Society is supporting research in this area.
Real stories
Real stories

Organised by the Premier League and the Professional Footballers’ Association (PFA), representatives from 16 Premier League and English Football League clubs and their charitable foundations came together at the Developing Dementia Initiatives workshop at Premier League headquarters in London.

Research
Research
Guest blogger, Professor Karen Watchman, explores the myths surrounding Down's syndrome and dementia.
Information
Information

We are thrilled to announce two exciting new partnerships through our Alzheimer’s Society Accelerator Programme, designed to support innovative dementia products and bring help and hope to people living with dementia. These collaborations mark significant steps in our ongoing mission to improve the lives of those affected by dementia.

Share your story with us

Find out how you can share your story with us to help engage hearts and minds and ensure dementia remains a public and political health priority.

Share your story with us